Kevin Cleveland, PharmD, ANP: Idaho Immunization Coalition: Consultant (Ongoing), Grant Recipient (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Seqirus, Inc.: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Can children receive PCV15 in place of PCV13? Who gets PPSV23? When does PCV20 come into play? Get your questions answered and hear the latest updates on immunization best practices from the most respected immunization experts in pharmacy.
This activity is supported by an independent educational grant from Merck Sharp and Dohme Corp.
Learning Objectives:
Differentiate between the pneumococcal vaccines.
Explain the clinical impact of serotype coverage in pneumococcal disease.
Summarize current ACIP recommendations for administration of pneumococcal vaccinations.
Determine the highest-risk groups who should receive the next generation of the pneumococcal vaccines.
Discuss the pharmacist’s and technician’s role in the promotion of pneumococcal vaccination.
